ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Pharmaceuticals Veterinary Vaccines Market Size Predicted to Reach USD 22.54 billion by 2033
Veterinary Vaccines Market

Veterinary Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Poultry, Aqua, Ruminants, Companion Animals) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH898DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Veterinary Vaccines Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Attenuated Live Vaccines
          1. By Value
        3. Inactivated Vaccines
          1. By Value
        4. Subunit Vaccines
          1. By Value
        5. DNA Vaccines
          1. By Value
        6. Recombinant Vaccines
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Poultry
          1. By Value
        3. Aqua
          1. By Value
        4. Ruminants
          1. By Value
        5. Companion Animals
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Attenuated Live Vaccines
          1. By Value
        3. Inactivated Vaccines
          1. By Value
        4. Subunit Vaccines
          1. By Value
        5. DNA Vaccines
          1. By Value
        6. Recombinant Vaccines
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Poultry
          1. By Value
        3. Aqua
          1. By Value
        4. Ruminants
          1. By Value
        5. Companion Animals
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Attenuated Live Vaccines
          1. By Value
        3. Inactivated Vaccines
          1. By Value
        4. Subunit Vaccines
          1. By Value
        5. DNA Vaccines
          1. By Value
        6. Recombinant Vaccines
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Poultry
          1. By Value
        3. Aqua
          1. By Value
        4. Ruminants
          1. By Value
        5. Companion Animals
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Attenuated Live Vaccines
          1. By Value
        3. Inactivated Vaccines
          1. By Value
        4. Subunit Vaccines
          1. By Value
        5. DNA Vaccines
          1. By Value
        6. Recombinant Vaccines
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Poultry
          1. By Value
        3. Aqua
          1. By Value
        4. Ruminants
          1. By Value
        5. Companion Animals
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Attenuated Live Vaccines
        1. By Value
      3. Inactivated Vaccines
        1. By Value
      4. Subunit Vaccines
        1. By Value
      5. DNA Vaccines
        1. By Value
      6. Recombinant Vaccines
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Poultry
        1. By Value
      3. Aqua
        1. By Value
      4. Ruminants
        1. By Value
      5. Companion Animals
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Attenuated Live Vaccines
          1. By Value
        3. Inactivated Vaccines
          1. By Value
        4. Subunit Vaccines
          1. By Value
        5. DNA Vaccines
          1. By Value
        6. Recombinant Vaccines
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Poultry
          1. By Value
        3. Aqua
          1. By Value
        4. Ruminants
          1. By Value
        5. Companion Animals
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Veterinary Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Indian Immunological Limited
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Ceva Sante Animale
    3. Zoetis
    4. Boehringer Ingelheim
    5. Phibro Animal Health Corporation
    6. Elanco Animal Health
    7. Virbac SA
    8. Biogenesis Bago
    9. Heska Corp
    10. Merck
    11. Bayer Pharma Ag
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Veterinary Services Market Size The global veterinary services market size was valued at USD 111.87 billion in 2024 and is expected to grow from USD 119.93 billion in 2025 to USD 209.16 billion by 2033, growing at a CAGR of 7.20%
Buy Now
Global Report
Viral Vaccines Market Size The global viral vaccines market size was valued at USD 55.07 billion in 2024 and is projected to grow from USD 57.72 billion in 2025 to reach USD 79.27 billion by 2033, growing at a 
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.